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In Brief
Diet affects the gut microbiota
composition, though large inter-
individual variations exist. Kovatcheva-
Datchary et al. reveal that subjects with
improved glucose metabolism after
barley kernel supplementation have
increased Prevotella in their gut
microbiota. Prevotella plays a direct role
in the beneficial response, supporting the
importance of personalized approaches
to improve metabolism.
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The gut microbiota plays an important role in human
health by interacting with host diet, but there is sub-
stantial inter-individual variation in the response to
diet. Here we compared the gut microbiota compo-
sition of healthy subjects who exhibited improved
glucose metabolism following 3-day consumption
of barley kernel-based bread (BKB) with those
who responded least to this dietary intervention.
The Prevotella/Bacteroides ratio was higher in re-
sponders than non-responders after BKB. Metage-
nomic analysis showed that the gut microbiota of
responders was enriched in Prevotella copri and
had increased potential to ferment complex poly-
saccharides after BKB. Finally, germ-free mice
transplanted with microbiota from responder human
donors exhibited improved glucose metabolism
and increased abundance of Prevotella and liver
glycogen content compared with germ-free mice
that received non-responder microbiota. Our find-
ings indicate that Prevotella plays a role in the
BKB-induced improvement in glucose metabolism
observed in certain individuals, potentially by pro-
moting increased glycogen storage.
INTRODUCTION
The gutmicrobiota interacts with the diet and impacts host phys-
iology andmetabolism (Tremaroli and Ba¨ckhed, 2012). Accumu-
lating data have demonstrated that the gut microbiota is altered
in individuals with obesity (Cotillard et al., 2013; Le Chatelier
et al., 2013), type 2 diabetes (Karlsson et al., 2013; Qin et al.,
2012), and stroke (Wang et al., 2011), suggesting that the gut mi-
crobiota may be an important environmental factor contributing
to development of metabolic diseases. A direct link between gut
microbiota and metabolic disease has been established using
germ-free (GF) mice, which have reduced adiposity and are pro-Cell Mtected against developing diet-induced obesity (Ba¨ckhed et al.,
2004, 2007).
Gut microbial ecology is to a large extent modulated by diet in
humans (David et al., 2014): high intake of fat and protein is asso-
ciated with increased levels of Bacteroides, whereas high fiber
intake is associatedwith increased levels ofPrevotella (De Filippo
et al., 2010; Koeth et al., 2013; Wu et al., 2011). Dietary interven-
tions are thus a potential tool to modulate gut microbiota and
further impact host health (Dewulf et al., 2013; Kovatcheva-
Datchary and Arora, 2013). We have previously shown that a
barley kernel-based evening meal (rich in non-starch polysac-
charides and resistant starch) improves glucose tolerance in
healthy subjects with a normal body mass index (BMI) (Johans-
son et al., 2013;Nilsson et al., 2006, 2008) andprovided evidence
of a link between colonic fermentation and glucose metabolism
(Johansson et al., 2013). However, there is large inter-individual
variation in the response to diet (Lampe et al., 2013), and recent
studies have indicated that the gut microbial composition could
be used to identify those subjects whowould benefit fromdietary
interventions (Korpela et al., 2014; Le Chatelier et al., 2013; Sal-
onen et al., 2014).
Here we compared the gut microbiota composition of healthy
subjects who exhibited improved glucose metabolism following
barley kernel-based bread (BKB) with those who responded
least to this dietary intervention to determine if differences in
gut bacteria could explain the beneficial effect of BKB in some
individuals.
RESULTS AND DISCUSSION
BKB Intervention Improves Glucose Metabolism in a
Subset of Healthy Humans
We have previously shown that BKB consumption is associ-
ated with improved postprandial glucose metabolism (Nilsson
et al., 2006), and in this study we selected two groups of indi-
viduals according to their response to BKB. We first measured
postprandial glucose and insulin responses in 39 healthy indi-
viduals following three consecutive days of dietary intervention
with BKB or white wheat flour bread (WWB) in a cross-over
study (biometric measurements of these subjects are listed
in Table S1). As expected, mean blood glucose and serumetabolism 22, 971–982, December 1, 2015 ª2015 Elsevier Inc. 971
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Figure 1. Glucose and Insulin Profiles in
Non-responders and Responders after a
Standardized Breakfast following 3-Day
Consumption of WWB or BKB
(A–E) Blood glucose and serum insulin responses
(A–D) and fasting breath hydrogen (H2) (E) in
non-responders (n = 10) and responders (n = 10)
following a standardized breakfast after 3-day
consumption of WWB or BKB. Data are mean ±
SEM (*p < 0.05; **p < 0.01; ***p < 0.001; and ****p <
0.0001; Student’s t test). Related to Figures S1 and
S3 and Table S1.insulin responses measured on day 4 after a standardized
breakfast were improved following BKB compared with
WWB in the total group (Figures S1A and S1B). In addition,
breath hydrogen excretion measured at breakfast was higher
following consumption of BKB compared with WWB (Fig-
ure S1C). From the total group, we selected the ten subjects
who showed the least or no improvement in glucose or insu-
lin responses (termed non-responders; Figures 1A and 1B)
and the ten subjects who showed the most pronounced
improvement in glucose and insulin responses (termed re-
sponders; Figures 1C and 1D) after the standardized breakfast
following BKB compared with WWB. Further details about the
selection criteria are included in Experimental Procedures.
Fasting breath hydrogen increased in both groups following
consumption of BKB (Figure 1E), indicating that the presence
of indigestible carbohydrates increased the fermentative ac-
tivity of the colonic microbiota in both responders and non-
responders.972 Cell Metabolism 22, 971–982, December 1, 2015 ª2015 Elsevier Inc.16S rRNA Sequencing of the Gut
Microbiota Shows Increased
Prevotella in Responders after BKB
To investigate if responders and non-re-
sponders differed in their gut microbiota
composition, we analyzed fecal samples
of these two groups by 454/Roche pyro-
sequencing of 16S rDNA genes. Prin-
cipal coordinate analysis (PCoA) of the
fecal microbiota sequencing data based
on the individual unweighted (presence/
absence information) UniFrac distances
(Lozupone et al., 2006) clustered primarily
by subjects (Figure S2A), suggesting that
each individual’s microbial community
comprises distinct assemblages ofmicro-
bial groups, in agreement with previous
studies (Wu et al., 2011). We further as-
sessed the microbial communities based
on the unweighted and weighted UniFrac
distances among responders and non-
responders on WWB, BKB, and at base-
line. We showed that supplementation of
the diet with WWB or BKB affected the
microbial community in the responders
but not in the non-responders (Figures
2A and S2B). Weighted UniFrac distance
between groups revealed that BKB inges-tion compared to WWB ingestion led to significant changes
in the relative abundance of specific members of the fecal
microbiota in the responders but not in the non-responders
(Figure 2A).
To further address this finding, we next analyzed the gut
microbiota composition of the responders and the non-re-
sponders at baseline and after BKB and WWB consumption.
Firmicutes and Bacteroidetes were the most common phyla in
both responders and non-responders, and we did not observe
different abundance at the phylum level between responders
and non-responders at baseline or after WWB consumption
(Figure 2B). However, after BKB consumption, the abundance
of Bacteroidetes increased in the responders but not in the
non-responders (Figure 2B). Bacteroidetes consists of two
main genera, Bacteroides and Prevotella, and the increase in
Bacteroidetes following BKB intervention in responders was
attributed to a bloom of Prevotella (Figure 2C). Prevotella did
not increase in the non-responders following BKB intervention
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Figure 2. Altered Gut Microbiota in Non-responders and Responders following 3-Day Consumption of WWB or BKB
(A) Weighted UniFrac distances in non-responders (n = 10) and responders (n = 10) at baseline and after 3-day consumption of WWB and BKB based on bacterial
V1-V2 16S rRNA pyrosequencing data. Data are mean ± SEM (*p < 0.05; ***p < 0.001; Student’s t test with 1,000 Monte Carlo simulations).
(B) Relative abundance of the major microbial phyla in non-responders and responders at baseline and after 3-day consumption of WWB and BKB (*p < 0.05
baseline versus BKB; Wilcoxon matched-pairs signed rank test corrected for FDR).
(C and D) Bacteroidetes phyla (C) and Prevotella/Bacteroides (D) ratio in non-responders and responders at baseline and after 3-day consumption of WWB and
BKB. Data are mean ± SEM (*p < 0.05; Wilcoxon matched-pairs signed rank test; ap = 0.056; Mann-Whitney U test). Related to Figure S2.(Figure 2C). Subjects with high levels of Prevotella usually have
lower levels of Bacteroides (Arumugam et al., 2011; Koren et al.,
2013; Wu et al., 2011), which implies that taxa from these
two genera compete for the same niche in the gut. We also
observed an increase in Prevotella/Bacteroides ratio following
BKB intervention versus baseline in the responders and a higher
Prevotella/Bacteroides ratio after BKB in responders versus
non-responders (Figure 2D). The increased Prevotella/Bacter-
oides ratio may be a consequence of the fact that responders
have a higher habitual fiber intake, as long-term intake of diets
rich in fiber are associated with increased abundance of Prevo-
tella (David et al., 2014; De Filippo et al., 2010; Wu et al., 2011).
However, both responders and non-responders exhibited
similar glucose responses to the WWB intervention (Figures
1A and 1C).
We next investigated whether the observed differences in the
abundance of Bacteroides and Prevotella between responders
and non-responders were accompanied by more widespread
shifts involving other members of the microbiota. At baseline,
the gut microbiota of the responders versus non-responders
had increased relative abundance of Dorea (p < 0.05, Kruskal-
Wallis test with a false discovery rate [FDR] correction) and a
trend toward an increase in Roseburia (p < 0.1, Kruskal-Wallis
test with an FDR correction; Figure S2C); both Dorea and Rose-
buria are genera of the Firmicutes phyla that are known to
metabolize dietary polysaccharides (Duncan et al., 2007). How-
ever, the abundance of these genera decreased following BKB
supplementation (Figure S2C), indicating that they are not the
key taxa involved in the degradation of indigestible carbohy-Cell Mdrates in responders. Methanogenic archaea may also poten-
tially contribute to the beneficial effects of the gut microbiota
as they improve the efficiency of polysaccharide fermentation
in the gut by preventing accumulation of H2 and other end prod-
ucts of fermentation (Pimentel et al., 2012). We therefore also as-
sessed the abundance of methanogenic archaea in responders
and non-responders before and after consumption of WWB
and BKB by quantifying the methyl coenzyme-M reductase
gene. We found that the abundance of methanogens was higher
after BKB ingestion in the responders compared with the non-re-
sponders (Figure S2D), which could contribute to the increased
efficiency of polysaccharide fermentation in these individuals
(Samuel and Gordon, 2006; Zhang et al., 2009).
We hypothesized that the different dominant bacterial lineages
in responders and non-responders may result in variations in
how the complex carbohydrates are fermented by the micro-
biota into metabolites such as short-chain fatty acids (SCFAs).
However, we did not observe any significant differences in the
fecal SCFA profile between responders and non-responders
(Figure S2E), which may be related to the inter-individual varia-
tion in the gutmicrobiota composition as suggested in a previous
dietary intervention study (Wu et al., 2014).
Phenotype of Responders and Non-responders Remains
Stable for One Year
To investigate the stability of the microbiota over time in these
subjects, we repeated the cross-over study with BKB and
WWB in 14 of the 20 original subjects (7 responders and 7non-re-
sponders) 12 months after the first study. Again we observed anetabolism 22, 971–982, December 1, 2015 ª2015 Elsevier Inc. 973
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Figure 3. Taxonomic Composition of the Metagenome of Non-responders and Responders at Baseline and after BKB Consumption
(A) Microbiota composition (family level) of non-responders and responders at baseline and after BKB. The ten top abundant families are shown. Data are mean ±
SD.
(B) Prevotella/Bacteroides ratio. Data are mean ± SD (*p < 0.05; Wilcoxon matched-pairs signed rank test; ap = 0.056; Mann-Whitney U test).
(C) Prevotella composition (species level) with total read abundance above 0.01. Data are mean ± SD. For statistics data, see Table S2. Related to Figure S4.improved postprandial blood glucose response after BKB inter-
vention in the subjects originally defined as responders but not
in those originally defined as non-responders (Figures S3A and
S3B). In addition, there was a trend toward an increase in the
Prevotella/Bacteroides ratio (measured by 16S qPCR) at this
time point after BKB in the responders versus the non-re-
sponders (Figure S3C), indicating that the microbiota remained
relatively stable over time.
ShotgunMetagenomeSequencing of theGutMicrobiota
Shows Increased Prevotella copri in Responders and
Functional Changes in the Metagenome in Response
to BKB
To validate the differences between the microbiota of non-
responders and responders, we also analyzed the fecal micro-
biota by shotgun metagenome sequencing. We generated on
average of 10.4 million (±0.89 SD) paired-end reads per sub-
ject (Table S2). Consistent with our 454-sequencing data, there
was a trend toward enrichment of Prevotellaceae in the meta-
genome of responders versus non-responders, and there was
a reduced abundance of Bacteroidaceae after BKB compared
with baseline in responders but not in non-responders (Fig-
ure 3A; Table S2). The Prevotella/Bacteroides ratio was higher
after BKB compared with baseline in responders and after
BKB in responders versus non-responders (Figure 3B). We
also showed that Prevotella copri was the most abundant974 Cell Metabolism 22, 971–982, December 1, 2015 ª2015 Elsevierof the Prevotellaceae species in the responders (Figure 3C;
Table S2).
We further studied the functional changes induced in the
metagenome of non-responders and responders after BKB
consumption compared to baseline and quantified the abun-
dance of genes encoding glycoside hydrolases, key enzymes
in carbohydrate digestion (Dodd et al., 2011). After BKB, we
observed a significant increase in abundance of genes encod-
ing xylan 1,4-beta-xylosidase, glucan endo-1,3-beta-D-gluco-
sidase, glucan 1,6-alpha-glucosidase, licheninase, and cellu-
lase in the responders but not in the non-responders (Table
S2). These enzymes are essential for the digestion of beta-glu-
cans and other complex polysaccharides in the BKB. These
findings thus suggest that the dietary fibers present in BKB
can be more efficiently digested by the metagenome of re-
sponders than non-responders and are in agreement with a
recent metagenomics analysis that linked the functional reper-
toire of Prevotella to increased capacity of the gut microbiota to
ferment complex polysaccharides from the diet (Rampelli et al.,
2015).
Increased Network Complexity and Prevotella-Enriched
Microbial Interactions in the Responders after BKB
To investigate if specific microbial co-occurrences could poten-
tially explain differences in the response to BKB, we used corre-
lation network analysis to study how Bacteroides and PrevotellaInc.
species interact with other species in the microbiota of non-re-
sponders and responders at baseline and after BKB. The result-
ing networks showed that the number of nodes (species) and
edges (interactions [correlations] between species) was higher
in the non-responders than in the responders at baseline and
after BKB (Table S3). However, the number of positive interac-
tions between species and the complexity of the interactions
(as shown by the average number of neighbors and the network
density [normalization of the average number of neighbors])
increased in the responders compared with the non-responders
after BKB (Table S3).
By using the network centralization parameter, which provides
insight into how the network density is distributed, we observed
that the interaction density was most centralized in the re-
sponders after BKB (Table S3; Figure S4). We observed a shift
in centrality from Bacteroides in non-responders to Prevotella
in responders; the hub nodes (nodes with the most interactions)
were Bacteroides species in the non-responders and Prevotella
species in the responders (Figure S4). The network analysis also
revealed that Prevotella species were highly abundant in the re-
sponders at baseline, whereas Bacteroides species were domi-
nant in the non-responders (Table S3; Figure S4). P. copri, which
was highly abundant in the metagenome of responders (Fig-
ure 3C), was present in all individuals at baseline but was more
than 2-fold higher in the responders and increased after BKB
(in terms of abundance and number of interactions with other
species) only in the responders (Table S3; Figure S4).
Changes in the abundance of microbial species in response to
diet depend not only on their interactions with other members of
the community, but also on the stability of those interactions in
response to disturbances and how the population will cope
afterward (Harmon et al., 2009). The network analysis showed
that Prevotella and Bacteroides were competing (i.e., negatively
correlated) with species from the Actinobacteria, Firmicutes, and
Proteobacteria phyla in both responders and non-responders at
baseline (Table S3; Figure S4). Members of the Actinobacteria
and Firmicutes phyla have been suggested to include species
that are primary degraders of complex carbohydrates (Flint
et al., 2012; El Kaoutari et al., 2013; Leitch et al., 2007; Ze
et al., 2012), suggesting that Prevotella and Bacteroides may
compete with those species for the same substrate. However,
after BKB in the responders, Prevotella species co-occurred
not only with other Prevotella species, but also with many spe-
cies from the Actinobacteria, Firmicutes, Proteobacteria, and
Archaea phyla (Table S3; Figure S4), suggesting that the niche
has expanded. We therefore speculate that Prevotellamay posi-
tively interact with the other members of the community to pro-
mote increased carbohydrate fermentation in the responders.
By contrast, after BKB in the non-responders, the network re-
mained dominated by Bacteroides species, and the number of
negative interactions between the microbes increased (Table
S3), suggesting that more species compete for the same sub-
strate in the non-responders.
Prevotella Improves Glucose Metabolism in Mice
To explore the potential of Prevotella species to improve glucose
metabolism, we gavaged mice with P. copri or control daily for
7 days and compared their glucose tolerance. In mice fed a stan-
dard chow diet (low in fat and protein and high in dietary fibers),Cell Mglucose tolerancewas improved following treatment with live hu-
man feces-derived P. copri (DSM 18205) compared with heat-
killed P. copri (experiment performed in two mouse strains;
Figures 4A and 4B). By contrast, P. copri did not have an effect
on glucose tolerance in mice fed a diet high in fat and low in
dietary fiber (Figure 4C). These results support the concept
that dietary fibers are important for Prevotella to colonize the
gut and to promote the beneficial effects on glucosemetabolism.
To directly investigate the effect of Bacteroides and Prevotella
species on glucose metabolism, we mono- and bi-colonized GF
mice with human feces-derived Bacteroides thetaiotaomicron
(ATCC 29148) and P. copri (DSM 18205) for 14 days. All mice
were fed a standard chow diet. WhileB. thetaiotaomicron utilizes
a vast range of plant and animal glucans (Martens et al., 2008,
2011; Xu et al., 2003), it lacks essential genes for degradation
of complex polysaccharides compared to other Bacteroides
strains (Dodd et al., 2010; Martens et al., 2011). By contrast,
P. copri possesses a number of enzymes and gene clusters
essential for fermentation and utilization of complex polysaccha-
rides (Dodd et al., 2011). Both bacteria colonized the gnotobiotic
mice to similar extents, and bi-colonization resulted in lower
levels of both bacteria (Figure 4D). Glucose tolerance was
impaired in mice colonized with B. thetaiotaomicron compared
with mice colonized with P. copri (Figure 4E). Importantly,
B. thetaiotaomicron-induced impairment of glucose tolerance
was prevented by simultaneous co-colonization with P. copri
(Figure 4E). The levels of B. thetaiotaomicron did not correlate
with area under the curve in the glucose tolerance test in either
mono-colonized (R2 = 0.11; p = 0.22) or bi-colonized (R2 = 0.10;
p=0.42)mice, indicating that the lowerB. thetaiotaomicron levels
in bi-colonized mice could not account for the improvement in
glucose tolerance. These data suggest that the different capac-
ity of P. copri and B. thetaiotaomicron to perform carbohydrate
fermentation in the mouse gut contributes to the differences
observed in terms of glucose metabolism and highlight the
importance of P. copri in improving glucose tolerance.
Bacteroides is known to produce propionate, whereas Prevo-
tella produces succinate (Macy et al., 1978). As expected,
propionate was the major metabolite in the cecum of mice
mono-colonized with B. thetaiotaomicron, whereas mice mono-
colonized with P. copri had high cecal levels of succinate and
no propionate production (Figure S5A). To investigate whether
the beneficial effects of Prevotella were mediated by the high
production of succinate, we generated a B. thetaiotaomicron
mutant, BT1686-89, that was unable to convert succinate into
propionate. Although colonization of GF mice with this strain re-
sulted in high cecal levels of succinate (Figure S5A), the glucose
response was not improved compared with mice colonized with
wild-type B. thetaiotaomicron (Figure S5B). Thus, the high levels
of succinate observed in mice mono-colonized with P. copri are
not sufficient to explain the beneficial effects of this bacterial
species.
Impaired Glucose Tolerance Is Associated with Altered
Gene Expression in Proximal Colon and Liver
To identify genes that could potentially explain the differ-
ence in glucose tolerance between mice colonized with
B. thetaiotaomicron and P.copri, we performed RNA sequencing
(RNA-seq) of proximal colon and liver biopsies from theetabolism 22, 971–982, December 1, 2015 ª2015 Elsevier Inc. 975
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Figure 4. Beneficial Effects of Prevotella on Glucose Metabolism in Mice Are Diet Dependent, and P. copri Protects against
B. thetaiotaomicron-Induced Glucose Intolerance
(A and B) Oral glucose tolerance test in (A) Swiss Webster and (B) C57BL/6 mice fed standard chow diet and gavaged with heat-killed P. copri or live P. copri for
7 days. Data are mean ± SEM (*p < 0.05, **p < 0.01; Student’s t test).
(C) Oral glucose tolerance test in C57BL/6 mice fed high-fat diet and gavaged with P. copri or media for 7 days. Data are mean ± SEM.
(D) Levels of B. thetaiotaomicron and P. copri determined by 16S rRNA specific qPCR following 14-day colonization of GFmice. Data are mean ± SEM (*p < 0.05;
Mann-Whitney U test).
(E) Oral glucose tolerance test following 14-day colonization of GF mice with B. thetaiotaomicron, P. copri, or both strains in Swiss Webster mice fed chow diet.
Data are mean ± SEM (*p < 0.05; **p < 0.01; Student’s t test; ap < 0.05 BT versus BT+P; Student’s t test). Related to Figure S5.mono- and bi-colonized mice and GF mice. We generated an
average of 14 million reads per sample, and more than 90% of
these reads were mapped to the mouse genome (Table S4).
We focused our analysis on genes that were significantly
up- or downregulated by colonization with B. thetaiotaomicron
but were not significantly altered by colonization with P. copri
or by bi-colonization with B. thetaiotaomicron and P. copri (all
compared to GFmice); we identified 601 such genes in the prox-
imal colon and 206 in the liver (Table S4).
The most significantly affected gene in the proximal colon was
G6pc, which encodes for glucose-6-phosphatase, a key enzyme
in intestinal gluconeogenesis that induces beneficial effects on
glucose and energy homeostasis (De Vadder et al., 2014); it
was downregulated by colonization with B. thetaiotaomicron
(Table 1). Two of the most significantly affected genes with an
impact on glucose metabolism in the liver were Sorbs1, which
encodes for sorbin and SH3 domain containing 1, a key protein
in insulin signaling (Lesniewski et al., 2007; Menzaghi et al.,
2008), and Pygl, which encodes for liver glycogen phosphory-
lase, an enzyme that catalyzes the breakdown of glycogen to
glucose (Bollen et al., 1998; Izumida et al., 2013); both genes
were upregulated by colonization with B. thetaiotaomicron (Ta-
ble 1). We next investigated if the changes in Pygl expression
were reflected by alterations in glycogen storage in liver and
showed that mice mono-colonized with B. thetaiotaomicron976 Cell Metabolism 22, 971–982, December 1, 2015 ª2015 Elsevierhad significantly lower hepatic glycogen content compared
with mice mono-colonized with P. copri (0.60 ± 0.14 versus
2.25 ± 0.21 mg/g liver; p < 0.0001).
Transmission of the Beneficial Effect of BKB on Host
Glucose Metabolism by Transplantation of the Human
Gut Microbiota
To investigate the potential of the non-responder- and
responder-associated microbiota to promote improvement in
host glucose metabolism after BKB, we transferred microbiota
from two non-responder and two responder human donors
at baseline and after BKB into GF mice. Postprandial blood
glucose and serum insulin responses after BKB and WWB and
the Prevotella/Bacteroides ratio at baseline and after WWB and
BKB of the selected non-responder and responder donors are
shown in Figure S6. We did not observe any differences in the
postprandial blood glucose response of mice colonized for
14 days with microbiota from either of the non-responder donors
taken at baseline or after BKB (Figures 5A and S7A). By contrast,
we observed an improved glucose response in mice colonized
for 14 days with microbiota from the responder donors after
BKB compared with mice colonized with microbiota from the
same donors taken at baseline (Figures 5B and S7B).
Wealsoused16SqPCR tomeasure the levels ofPrevotellaand
Bacteroides in the cecum of mice colonized with non-responderInc.
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Figure 5. Transfer of a Responder’s Gut
Microbiota Taken after BKB to GF Mice
Improves Glucose Tolerance
(A and B) Oral glucose tolerance test in recipient
Swiss Webster male mice colonized with (A)
non-responder donor 1 or (B) responder donor 1
microbiota taken at baseline and after BKB. Data
are mean ± SEM (*p < 0.05; Student’s t test).
(C and D) Levels of (C) Prevotella and (D) Bacter-
oides in the cecum of recipient mice after 14 days
of colonization, determined by 16S rRNA specific
qPCR. Data are mean ± SEM (*p < 0.05; **p < 0.01;
Mann-Whitney U test).
(E)Prevotella toBacteroides ratio. Data aremean ±
SEM (**p < 0.01; ****p < 0.0001; Mann-Whitney U
test). Related to Figures S6 and S7.and respondermicrobiota at baseline andafter BKB. The levels of
Prevotella were higher in mice colonized with responder versus
non-responder donor microbiota taken at baseline and were
further increased in mice colonized with responder microbiota
taken after BKB (Figures 5C and S7C). Levels of Bacteroides
were slightly but not significantly higher in the cecum of the
mice colonized with non-responder versus responder donor mi-
crobiota andwere similar inmice colonizedwithmicrobiota taken
at baseline or after BKB (Figures 5D and S7D). In addition, the
Prevotella/Bacteroides ratiowas significantly higher inmice colo-
nized with responder versus non-responder donor microbiota
taken at baseline and increased further in mice that received
responder microbiota taken after BKB (Figures 5E and S7E).
These observations further support our hypothesis that BKB-
induced changes in the microbiota are sufficient to promote
beneficial responses in the host and, specifically, that increased
abundance of Prevotella after BKB improves glucose tolerance.
Wealsomeasured relativeexpressionofgenes thatwerediffer-
entially regulated in mice colonized with B. thetaiotaomicronCell Metabolism 22, 971–982,and P.copri and that could potentially
play a role in glucosemetabolism (Table 1)
in tissues from mice that received micro-
biota from responder and non-responder
donors at baseline and after BKB. We
identified significantly increased expres-
sion of G6Pc in proximal colon biopsies
from the mice colonized with responder
versus non-responder microbiota taken
after BKB (Figure 6A). We also observed
a significant decrease in Sorbs1 in liver
from mice colonized with responder and
non-responder microbiota taken after
BKBcomparedwith the respectivemicro-
biota taken at baseline (Figure 6B). How-
ever, Pygl decreased significantly in liver
from mice colonized with responder but
not non-responder microbiota taken after
BKB versus microbiota taken at baseline
(Figure 6C).
We next investigated if the changes in
Pygl expression were reflected by alter-
ations in glycogen storage in liver frommice colonized with responder versus non-responder micro-
biota. We showed that hepatic glycogen content was signifi-
cantly higher in mice colonized with responder microbiota taken
after BKB than in mice colonized with responder microbiota
taken at baseline or with non-responder microbiota taken after
BKB or at baseline (Figure 6D). These findings suggest that
Prevotella may contribute to the BKB-induced improvement in
glucose metabolism observed in some (but not all) individuals
by promoting increased glycogen storage.
Perspective
In summary, we have shown that alterations in the gutmicrobiota
contribute to the beneficial metabolic benefits induced by short-
term dietary supplementation with indigestible carbohydrates in
a subgroup of healthy humans. Our study also highlights the
potential importance of individual members of the gutmicrobiota
(both in terms of abundance and their interactions with other mi-
crobial species) to host metabolism and responses to changes
in diet. Our findings support the importance of personalizedDecember 1, 2015 ª2015 Elsevier Inc. 977
Table 1. Top Ten Significantly Regulated Genes in Biopsies from Proximal Colon and Liver of Mice Mono-Colonized with
B. thetaiotaomicron
Tissue Gene Name Log2 Fold change p value p-adj Description
Proximal colon G6pc 2.75 1E-10 5.4E-08 glucose-6-phosphatase, catalytic
Apoa4 3.51 4E-08 8.1E-06 apolipoprotein A-IV
Sprr2a3 1.15 5E-08 1E-05 small proline-rich protein 2A3
Saa2 1.09 8E-08 1.6E-05 serum amyloid A 2
Pepd 0.57 8E-08 1.6E-05 peptidase D
Enpep 1.01 2E-07 2.9E-05 glutamyl aminopeptidase
Gsdmcl2 2.41 3E-07 5E-05 gasdermin C-like 2
Nfkbia 0.39 4E-07 6.1E-05 nuclear factor of kappa light polypeptide gene enhancer
in B cells inhibitor
Slc38a2 0.36 1E-06 0.00015 solute carrier family 38, member 2
Mfsd8 0.45 1E-06 0.00015 major facilitator superfamily domain containing 8
Edn1 0.82 2E-06 0.00025 Endothelin
Liver Sorbs1 0.60 5E-06 0.00033 sorbin and SH3 domain containing 1
Bdh2 0.97 1E-05 0.00062 3-hydroxybutyrate dehydrogenase, type 2
Chka 0.81 1E-05 0.00068 choline kinase alpha
Camk2b 1.57 1E-05 0.00073 calcium/calmodulin-dependent protein kinase II, beta
Cd9 0.69 2E-05 0.00102 CD9 antigen
Lrig2 0.60 3E-05 0.00138 leucine-rich repeats and immunoglobulin-like domains 2
Hist1h1e 0.85 5E-05 0.00188 histone cluster 1, H1e
Ergic1 0.41 6E-05 0.00223 endoplasmic reticulum-golgi intermediate compartment
(ERGIC) 1
Pygl 0.41 7E-05 0.00244 liver glycogen phosphorylase
Atp6v0e2 1.10 8E-05 0.00268 ATPase, H+ transporting, lysosomal V0 subunit E2
Related to Table S4.approaches to improve host metabolism and emphasize the
possibility of using a synbiotic approach involving both diet
and microbiota to treat metabolic disorders. It is important to
note that our findings need to be validated in a larger cohort. A
further step will be to perform a prospective follow-up study
that uses gut microbiota composition as a strategy to identify
the individuals who would benefit from a dietary intervention.
EXPERIMENTAL PROCEDURES
Test Subjects and Study Design
In total, 39 subjects (6 men, 33 women) participated in the study (Table S1).
The inclusion criteria were: age 50–70 years, BMI normal to slightly overweight
(BMI 18–28 kg/m2), fasting plasma glucose% 6.1 mmol/l, non-smoker, overall
healthy, and no knownmetabolic disorders or food allergies. Anti-hypertensive
medications and prescription-free painkillers without any anti-inflammatory
action were accepted. None of the participants in the study had a partner or
spousewho participated in the study. The studywas approved by the Regional
Ethical Review Board in Lund, Sweden (Reference 2010/457).
We used a randomized cross-over design to test the effect of BKB versus
WWB on glucose metabolism. The composition of the BKB and WWB and
the experimental procedure have been described earlier (Nilsson et al.,
2015). In brief, each subject participated in two 3-day interventions where
they consumed either BKB or WWB in a random order separated by a mini-
mum of 2 weeks. After the evening meal on day 3 of the intervention period,
the subjects fasted until the standardized breakfast, which was served the
next morning at the experimental department (the test day). Fasting blood
samples were collected and breath hydrogen was registered before breakfast
was served at 8:00. Finger-prick capillary blood samples were taken for deter-
mination of blood glucose (HemoCue B-glucose). Venous blood samples were978 Cell Metabolism 22, 971–982, December 1, 2015 ª2015 Elseviercollected to determine serum insulin. Serum was separated by centrifugation
and immediately stored in a freezer (40C) until analysis. Breath hydrogen in
expired air was measured using a Gastro+ (Bedfont EC60 Gastrolyzer). Re-
sults on glucose and insulin responses and breath hydrogen excretion in 20
of these subjects have been reported previously (Nilsson et al., 2015).
Fecal samples were collected before the dietary intervention (defined as
baseline) and from the first defecation that occurred on day 4 after BKB or
WWB (the test days). The sample was immediately frozen and handed over
to the experimental department within 24 hr for continued storage at 80C
until analysis.
Selection of Responders and Non-responders
From the total group, we selected a group of ten responders (two men, eight
women) who showed all of the following responses after the standardized
breakfast following BKB compared with WWB: (1) incremental blood glucose
area (IAUC, 0–90 min) decreased by at least 25%, (2) total AUC (0–90 min)
decreased, and (3) insulin IAUC (0–90 min) decreased by at least 15%. From
the remaining 29 subjects, we selected a group of ten non-responders (all
women), defined as those who showed the least improvements in glucose
and/or insulin responses after the standardized breakfast following BKB
compared with WWB. Of these, neither the glucose nor insulin responses
were affected by BKB in four subjects, the glucose response but not the insulin
response was slightly affected in three subjects, and the insulin response but
not the glucose response was slightly affected in three subjects.
Genomic DNAPurification, Amplification, Pyrosequencing, andData
Analysis
After isolation of genomic DNA from feces using repeated bead beating
(Salonen et al., 2010), the V1-V2 variable region of the 16 rRNA gene was
amplified using the 27F and 338R primers as previously reported (De Vadder
et al., 2014). The pooled products were sequenced using the 454 GS FLXInc.
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Figure 6. Transfer of a Responder’s Gut Microbiota Taken after BKB to GF Mice Promotes Hepatic Glucose Storage as Glycogen
(A–C) Relative expression of (A) G6pc in proximal colon, (B) Sorbs1 in liver, and (C) Pyg1 in liver of recipient mice colonized with non-responder or responder
microbiota taken at baseline and after BKB. Data are mean ± SEM (*p < 0.05;**p < 0.01; Mann-Whitney U test).
(D) Glycogen in the liver of recipient mice colonized with non-responder or responder microbiota taken at baseline and after BKB. Data are mean ± SEM (****p <
0.0001; ANOVA with Tukey post-hoc test).System and Titanium Chemistry (Roche) at National Genomics Infrastructure
(Stockholm).
Raw data were quality filtered to remove sequences that were shorter
than 200 nucleotides, were longer than 1,000 nucleotides, or contained primer
mismatches, ambiguous bases, uncorrectable barcodes, or homopolymer
runs in excess of six bases. Quality-filtered reads were trimmed from their
454 adapters and barcode sequences and were analyzed with the software
package Quantitative Insights into Microbial Ecology (QIIME) (version 1.5.0).
In total, 755,963 reads passed the quality filter (mean 12,599 sequences/sam-
ple). The sequencing data were de-noised with denoise_wrapper.py in QIIME.
Sequences were assigned to operational taxonomic units (OTUs) using
UCLUST with a 97% threshold of pairwise identity. The most abundant
sequence was picked as representative for each OTU and was taxonomically
assigned using the Ribosomal Database Project Classifier. Representative
OTUs were aligned using Pynast and used to build a phylogenetic tree with
FastTree, which was used to estimate b-diversity of samples (weighted and
unweighted UniFrac).
Shotgun Metagenome Analysis
The metagenome DNA samples were sequenced in paired-end mode
(2*151 bp) with NextSeq500 at the core facility of Gothenburg University.
Each single read sequence was annotated individually for both functional
and taxonomical profiles using the Metagenome rapid annotation (MG-RAST)
server (Meyer et al., 2008). More detailed information of the analysis is included
in the Supplemental Information.
Network Co-occurrence Analysis
For the network analysis, all possible Spearman’s correlations between abun-
dance of Bacteroides and Prevotella species with the other species in the
microbiota were calculated in responders and non-responders at baselineCell Mand after BKB in each group separately (using data from the metagenomic
analysis). To reduce network complexity, we only used species that had a
minimum of five sequences in at R 4 individuals (out of 10 in each group).
All the statistical analyses were performed in R (R Core Team, 2015), and p
values were corrected using the FDR method (Benjamini and Hochberg,
1995). An acceptable co-occurrence interaction was considered to have an
absolute correlation coefficient of > 0.6 and an adjusted p value of < 0.05. Net-
works were visualized using Cytoscape 3.0.2 (Kofia et al., 2015) with a Prefuse
Force Directed Layout. NetworkAnalyzer tool in Cytoscape was used to
analyze the networks individually.
16S rRNA Quantitative PCR
16S rRNA quantitative PCR was performed with a CFX96 Real-Time System
(Bio-Rad). All reactions were performed in duplicate in one run and in duplicate
PCR runs. qPCR was performed as reported previously: for Bacteroides
(Walker et al., 2011), for the methyl coenzyme-M reductase gene (Denman
et al., 2007), for Prevotella (Matsuki et al., 2002), and for B. thetaiotaomicron
(Samuel and Gordon, 2006). More detailed information of the analysis is
included in the Supplemental Information.
Mouse Experiments with P. copri
We performed three experiments to test the effect of P. copri in mice. In the
first experiment, adult Swiss Webster and C57BL/6 male mice (Taconic) on
a chow diet were gavaged daily for 7 consecutive days with live or heat-killed
control P. copri (five mice per group). In the second experiment, C57BL/6 male
mice were fed a high-fat diet (40.6% kcal from fat; TD.09683 Harlan Teklad) for
4 weeks and gavaged for 7 consecutive days with live P. copri or media con-
trol. In the third experiment, 10- to 12-week-old GF Swiss Webster male mice
on a chow diet were inoculated with single gavage of 108 CFU P. copri strain
DSM18205 and/or B. thetaiotaomicron strain ATCC 29148 or the isogenicetabolism 22, 971–982, December 1, 2015 ª2015 Elsevier Inc. 979
B. thetaiotaomicron mutant strain (BT1686-89). Mono- and bi-colonized mice
were housed in an iso-cage system for 14 days. An oral glucose tolerance test
(OGTT) was performed at the end of all of these experiments. All mice exper-
iments were performed using protocols approved by the University of Gothen-
burg Animal Studies Committee.
Transfer of Human Feces into Mice
Fecal samples from selected responders and non-responders at baseline and
after BKB consumption (see Figure S6) were added to PBS buffer supple-
mentedwith reducing solution (Na2S and cysteine dissolved in NaHCO3 buffer)
and transferred to 10- to 12-week-old GF Swiss Webster male and female
mice (5–7 per group) via oral gavage. The mice were colonized for 14 days.
An OGTTwas performed at the end of the experiment. Liver, cecum, and colon
were harvested, immediately snap-frozen in liquid nitrogen, and stored at
80C until further processing.
RNA Extraction and RNA Sequencing
Mouse tissues from liver and proximal colon were homogenized in RLT buffer
using a TissueLyzer (QIAGEN). RNA was isolated using the Qiacube (QIAGEN)
following the manufacture protocol. RNA quantity and quality were examined
with a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies).
The RNA samples were sequenced at the genomics core facility of Gothen-
burg University in a paired-end mode with Nextseq500 (2*75). The qualities of
the sequences (reads) were evaluated using MAXINFO algorithm in Trimmo-
metric software (Bolger et al., 2014). More detailed information is included in
the Supplemental Information.
RT qPCR
cDNA was synthesized using the High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). qRT-PCR reactions were set up in a 10 ml volume
containing 13 SYBR Green Master Mix buffer (Thermo Scientific) and
900 nM gene-specific primers (or 300 nM L32 primers). Reactions were
run on a CFX96 Real-Time System (Bio-Rad). Gene expression data were
normalized to the ribosomal protein L32 using the DDCT method. The primer
sequences are listed in the Supplemental Information.
Glycogen Measurement
Glycogen determination was carried out on grinded frozen liver homogenates
as described previously (Pfleiderer, 1974).
Calculations and Statistical Methods
Values are presented as means ± SEM. For graph plotting and statistical
analysis, we used GraphPad Prism (version 6, GraphPad Software) unless
otherwise indicated. Statistical comparison of two groups was performed by
Student’s t test, Wilcoxon matched-pairs signed rank test, and Mann-Whitney
U test; comparisons of three or more groups were performed by one-way
analysis of variance (ANOVA) and corrected for multiple comparison with
Tukey post-tests.
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